基因编辑CRISPR/Cas9:对阿尔茨海默氏症治疗的新方法
Siddhant Tripathi1, Yashika Sharma1, Rajesh Rane1
1Department of Pharm Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune Maharashtra 411038, India.
CNS & neurological disorders drug targets
|May 8, 2024
概括
对阿尔茨海默病 (AD) 的CRISPR-Cas9基因编辑的研究提供了新的治疗策略. 这项技术显示了纠正与AD相关的基因序列的潜力,包括APOE4基因,推进AD研究和治疗.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是蛋白,β-粉样斑块和认知能力下降.
- 尽管进行了广泛的研究,但阿尔茨海默病的有效治疗仍然难以捉摸,需要新的治疗方法.
研究的目的:
- 分析CRISPR-Cas9基因编辑技术在阿尔茨海默病 (AD) 调查和治疗中的潜力.
- 探索CRISPR-Cas9在开发AD研究的体外和体内模型中的应用.
- 解决在AD治疗中使用CRISPR-Cas9传递方法的挑战.
主要方法:
- 审查CRISPR-Cas9技术及其作用机制 (通过双链断裂的基因失活/纠正).
- 在AD模型中分析CRISPR-Cas9应用.
- 讨论基因标,包括早期和晚期发作的AD风险因素,如阿波利波蛋白E4 (APOE4) 基因.
主要成果:
- 克里斯普尔-Cas9因其对纠正与阿尔茨海默病有关的基因序列的潜力显著感兴趣.
- 该技术可用于创建先进的体外和体内模型来研究AD.
- 对CRISPR-Cas9的传递方法是其治疗应用的关键障碍.
结论:
- 克里斯普尔-Cas9技术作为阿尔茨海默病的潜在治疗策略具有前景.
- 对传递系统的进一步研究对于实现CRISPR-Cas9在治疗AD的临床潜力至关重要.
- 用CRISPR-Cas9针对特定的AD相关基因,如APOE4,是一个可行的研究方向.
更多相关视频
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.6K
11:28Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
Published on: May 23, 2016
17.6K
相关概念视频
01:59CRISPR
50.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.7K
02:53CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
00:49What is Genetic Engineering?
74.1K
Overview
74.1K